Anti-Infective Drugs Global Market Is Expected To Grow Close To $133 Billion By 2021 According To TBRC’s Latest Report

Posted July 5, 2018 by sainath

North America was the largest region in the anti-infective drugs market in 2017, accounting for 30% market share. The USA was the largest country in the market in 2017, accounting for nearly 25% market share.
Infectious diseases are disorders caused by several pathogenic organisms such as bacteria, viruses, fungi or parasites. These diseases can be transmitted or spread from one person to another through direct contact or indirect contact. Anti-infective drugs are used to treat or prevent these infectious diseases by inhibiting the spread of an infectious agent (static) or by killing the infectious agent (cidal).

Read More:

The major reason why the global anti-infective drugs market will increase from $117 billion in 2017 to $133 billion by 2021 is the growth of infectious diseases caused by bacteria, viruses, fungi and the expected increase in global healthcare expenditure.

In the report, the global anti-infective drugs market is divided into four segments, namely antivirals, antibiotics, antifungals and others (antihelmethic, antiprotozoal). While the first segment accounts for more than half of the market share, the remaining share is attributed to the other three segments.

Sample Report:

The USA was the largest country in the anti-infective drugs market in 2017, accounting for nearly one-fourth of the market share. This can be attributed to the increased healthcare expenditure per capita in the country and the availability of a wide network of healthcare facilities. China and Italy followed the USA as the next largest countries in the market.

The anti-infective drugs market is fragmented into a number of large and small organizations. The top five competitors in the market made up around 30% of the total market in 2017. Gilead Sciences, Inc. was the largest competitor of the market, followed by Merck & Co. and GlaxoSmithKline Plc. Gilead is an American biopharmaceutical company that discovers, develops and commercializes therapeutics for areas such as cardiovascular and inflammation/respiratory diseases, hematology/oncology, human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection. The company was founded in 1987 and is headquartered in Foster City, California, United States.

About The Business Research Company.

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information.

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
-- END ---
Contact Email [email protected]
Issued By Sainath
Website The Business Research Company
Phone +442071930708
Business Address 47 Anchorage Point,
42 Cuba Street, Canary Wharf,
Country United Kingdom
Categories Business , Health , Medical
Tags Anti-Infective Drugs Global Market Report 2018 , Antibiotics Market Report , Antifungal Drugs Market Report , Antivirals Market Report , Antihelmethic Market Report , Antiprotozoal Drugs Market Report
Last Updated July 5, 2018